Co-Authors
This is a "connection" page, showing publications co-authored by Brandon Henry and Fabian Sanchis-Gomar.
Connection Strength
6.454
-
Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis. Clin Chem Lab Med. 2022 01 26; 60(1):e1-e3.
Score: 0.241
-
Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection. Ann Intern Med. 2021 06; 174(6):885-886.
Score: 0.237
-
Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study. J Clin Pathol. 2021 Mar 31.
Score: 0.234
-
Response to: Eosinophil count in coronavirus disease 2019: more doubts than answers. QJM. 2021 02 18; 114(1):70-71.
Score: 0.233
-
Pooled analysis of monocyte distribution width in subjects with SARS-CoV-2 infection. Int J Lab Hematol. 2021 08; 43(4):O161-O163.
Score: 0.232
-
Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA. Eur J Hosp Pharm. 2021 Jan 27.
Score: 0.232
-
CT-Determined Maximum Pulmonary Artery to Ascending Aorta Diameter Ratio in Nonsevere COVID-19 Patients. Acad Radiol. 2021 03; 28(3):440-441.
Score: 0.231
-
Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness. Semin Thromb Hemost. 2021 06; 47(4):460-462.
Score: 0.230
-
Putative impact of the COVID-19 pandemic on anxiety, depression, insomnia and stress. Eur J Psychiatry. 2021 Jul-Sep; 35(3):200-201.
Score: 0.229
-
Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity? J Diabetes. 2021 02; 13(2):179-180.
Score: 0.228
-
Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. J Diabetes. 2020 Nov; 12(11):851-855.
Score: 0.228
-
Coronavirus Disease 2019-Associated Coagulopathy. Mayo Clin Proc. 2021 01; 96(1):203-217.
Score: 0.228
-
Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing. Infect Control Hosp Epidemiol. 2021 11; 42(11):1405-1406.
Score: 0.228
-
In reply- Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19. Mayo Clin Proc. 2020 11; 95(11):2561-2563.
Score: 0.226
-
Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 2019. Acta Haematol. 2021; 144(4):360-364.
Score: 0.225
-
Repeated Testing in SARS-CoV-2 Infection. Mayo Clin Proc. 2020 10; 95(10):2283-2284.
Score: 0.224
-
Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Clin Chem Lab Med. 2020 08 27; 58(9):1415-1422.
Score: 0.222
-
Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China. J Med Virol. 2020 10; 92(10):1759-1760.
Score: 0.221
-
COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon. Ann Transl Med. 2020 Jun; 8(11):693.
Score: 0.221
-
Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis (Berl). 2020 05 26; 7(2):85-90.
Score: 0.221
-
In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Mayo Clin Proc. 2020 07; 95(7):1553-1556.
Score: 0.221
-
Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide. Mayo Clin Proc. 2020 07; 95(7):1445-1453.
Score: 0.221
-
Active smoking and COVID-19: a double-edged sword. Eur J Intern Med. 2020 07; 77:123-124.
Score: 0.220
-
Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis. Curr Probl Cardiol. 2020 Aug; 45(8):100617.
Score: 0.220
-
Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19). Eur J Prev Cardiol. 2020 06; 27(9):906-908.
Score: 0.219
-
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019. Mayo Clin Proc. 2020 06; 95(6):1222-1230.
Score: 0.219
-
Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm. Ann Transl Med. 2020 Apr; 8(7):497.
Score: 0.219
-
Searching for a clinically validated definition of "asymptomatic" COVID-19 infection. Int J Clin Pract. 2021 Sep; 75(9):e14085.
Score: 0.060
-
Is COVID-19 impacting prostate cancer screening? A survey of prostate-specific antigen test requests during a local outbreak. EJIFCC. 2021 Feb; 32(1):69-77.
Score: 0.058
-
Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis. Semin Thromb Hemost. 2021 Jun; 47(4):392-399.
Score: 0.058
-
SARS-CoV-2 recurrent RNA positivity after recovering from coronavirus disease 2019 (COVID-19): a meta-analysis. Acta Biomed. 2020 09 07; 91(3):e2020014.
Score: 0.056
-
Updates on laboratory investigations in coronavirus disease 2019 (COVID-19). Acta Biomed. 2020 09 07; 91(3):e2020030.
Score: 0.056
-
COVID-19 and obesity: links and risks. Expert Rev Endocrinol Metab. 2020 07; 15(4):215-216.
Score: 0.055